A Study of PLB1001 in Non-small Cell Lung Cancer With c-Met Dysregulation(KUNPENG)
Clinical trial NCT04258033 · COMPLETED
Trial details
- NCT number
- NCT04258033
- Sponsor
- Beijing Pearl Biotechnology Limited Liability Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-17
- Primary completion
- 2024-05-14
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.